<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref51">
 <mixed-citation publication-type="journal" id="cit51">
  <name>
   <surname>Wang</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Li</surname>
   <given-names>W.</given-names>
  </name>; 
  <name>
   <surname>Drabek</surname>
   <given-names>D.</given-names>
  </name>; 
  <name>
   <surname>Okba</surname>
   <given-names>N. M. A.</given-names>
  </name>; 
  <name>
   <surname>van Haperen</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Osterhaus</surname>
   <given-names>A. D. M. E.</given-names>
  </name>; 
  <name>
   <surname>van Kuppeveld</surname>
   <given-names>F. J. M.</given-names>
  </name>; 
  <name>
   <surname>Haagmans</surname>
   <given-names>B. L.</given-names>
  </name>; 
  <name>
   <surname>Grosveld</surname>
   <given-names>F.</given-names>
  </name>; 
  <name>
   <surname>Bosch</surname>
   <given-names>B. J.</given-names>
  </name>
  <article-title>A human monoclonal antibody blocking SARS-CoV-2 infection</article-title>. 
  <source>Nat. Commun.</source>
  <year>2020</year>, 
  <volume>11</volume>, 
  <fpage>2251</fpage>
  <pub-id pub-id-type="doi">10.1038/s41467-020-16256-y</pub-id>.
  <pub-id pub-id-type="pmid">32366817</pub-id>
 </mixed-citation>
</ref>
